NSGCCE
Nottingham Support Group for Carers of Children with Eczema
University of Nottingham
  

What The Papers Say: Asthma, Eczema Sufferers Get Dramatic Relief From New Allergy Drug

The allergy drug, dupilumab, is meant to treat underlying causes of asthma, eczema and nasal polyps and could transform treatment of those suspected related ailments, the officials say.

To read more about this article, please follow this link to the NewsMax Health website.

See more eczema-related news headlines on What The Papers Say.

 

Posted on Monday 22nd September 2014

Disclaimer
Contact us

Nottingham Support Group for Carers of Children with Eczema (NSGCCE)

©2006 – 2022 NSGCCE and its contributors.

Website: www.nottinghameczema.org.uk

Email: enquiry@nottinghameczema.org.uk